Innate Pharma S.A. ADR (IPHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IPHA | AMGN | BMY | VRTX | GILD |
| Company | Innate Pharma S.A. ADR | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 2.03 | 263.37 | 57.70 | 401.53 | 93.55 |
| High | 2.03 | 263.37 | 57.70 | 410.68 | 93.55 |
| Low | 2.03 | 263.37 | 57.70 | 401.27 | 93.55 |
| Last | 2.03 | 263.37 | 57.70 | 408.18 | 93.55 |
| Change | -0.03 | -1.12 | -0.06 | +2.91 | -0.40 |
| % Change | -1.46% | -0.42% | -0.10% | +0.72% | -0.43% |
| Volume | 1,086 | 3,009 | 2,388 | 1,468,500 | 1,405 |
| 20-Day Average Volume | 1,472,554 | 4,150,325 | 11,019,904 | 1,832,675 | 6,953,070 |
| Previous Close | 2.06 | 264.49 | 57.76 | 405.27 | 93.95 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.87 | 271.18 | 57.81 | 452.00 | 92.41 |
| 20-Day Raw Stochastic | 29.51% | 33.19% | 52.69% | 30.76% | 80.00% |
| 20-Day Relative Strength | 52.31% | 32.82% | 53.76% | 33.99% | 56.94% |
| Weighted Alpha | -55.07 | -15.10 | +20.34 | -7.89 | +25.35 |
| Today's Opinion | 24% Sell | 88% Sell | 80% Buy | 72% Sell | 100% Buy |
| Previous Opinion | 24% Sell | 88% Sell | 80% Buy | 72% Sell | 100% Buy |
| Last Month's Opinion | 100% Sell | 72% Sell | 100% Buy | 24% Sell | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.02% since 12/18/24 | +1.77% since 12/18/24 | +1.51% since 12/18/24 | -13.01% since 12/17/24 | +3.15% since 12/18/24 |
| Low | 2.01 on 12/23/24 | 253.30 on 12/19/24 | 56.08 on 12/20/24 | 377.85 on 12/19/24 | 90.27 on 12/19/24 |
| High | 2.18 on 12/19/24 | 269.61 on 12/20/24 | 57.77 on 12/24/24 | 471.05 on 12/18/24 | 94.05 on 12/24/24 |
| 1-Month | |||||
| %Chg | +35.33% since 11/26/24 | -5.94% since 11/26/24 | -1.77% since 11/26/24 | -9.49% since 11/22/24 | +2.41% since 11/26/24 |
| Low | 1.41 on 12/04/24 | 253.30 on 12/19/24 | 55.04 on 12/13/24 | 377.85 on 12/19/24 | 89.15 on 12/13/24 |
| High | 3.51 on 12/13/24 | 283.64 on 11/29/24 | 60.09 on 12/03/24 | 476.46 on 12/10/24 | 94.65 on 12/11/24 |
| 3-Month | |||||
| %Chg | -5.58% since 09/26/24 | -17.46% since 09/26/24 | +15.12% since 09/26/24 | -11.84% since 09/24/24 | +12.66% since 09/26/24 |
| Low | 1.29 on 11/18/24 | 253.30 on 12/19/24 | 50.71 on 09/27/24 | 377.85 on 12/19/24 | 82.82 on 10/01/24 |
| High | 3.51 on 12/13/24 | 329.17 on 10/11/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +0.50% since 06/26/24 | -15.81% since 06/26/24 | +35.76% since 06/26/24 | -14.06% since 06/24/24 | +34.97% since 06/26/24 |
| Low | 1.29 on 11/18/24 | 253.30 on 12/19/24 | 39.35 on 07/05/24 | 377.85 on 12/19/24 | 66.01 on 07/05/24 |
| High | 3.51 on 12/13/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 170,572 | 142,172,096 | 117,147,504 | 105,118,176 | 117,086,688 |
| Shares Outstanding, K | 82,802 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 66,710,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -8,190,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | N/A | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | N/A | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 0.34 | 0.55 | 0.45 | 0.36 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/13/24 | 02/04/25 | 02/06/25 | 02/03/25 | 02/11/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 12/13/24 |
| Next Ex-Dividends Date | N/A | 02/14/25 | 01/03/25 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.74 | 49.21 | 0.00 | 21.08 |